Clinical Trial Update: Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring cytokine and visual outcomes in eyes treated with aflibercept for age-related macular degeneration and diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema
• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Unity Health Toronto | Conditions: Age Related Macular Degeneration, Diabetic Macular Edema | Phase 4 | Status: UNKNOWN